Reckitt Benckiser (Australia) Pty Ltd v GlaxoSmithKline Australia Pty Ltd (No 2) [2018] FCAFC 153
The Court found the rejection of the offer was not unreasonable because the appeal was genuinely arguable, commercially significant to the appellant, and the quantum of costs was not provided. Therefore, indemnity costs were not warranted and only party and party costs were ordered.
- Jurisdiction
- Australia
- Judgment Date
- 14 September 2018
- Procedural Posture
- Appeal / Post Judgment Application for Costs
- Outcome
- Appellant ordered to pay respondents' costs of the appeal on a party and party basis.
- Legal Topics
- ['indemnity Costs' 'offer of Compromise' 'party and Party Costs']
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Procedural Posture
Appeal / Post Judgment Application for Costs
Legal Issues
- 1 ["Whether the appellant's rejection of an offer of compromise was unreasonable for the purposes of indemnity costs under the Federal Court Rules 2011 (Cth), r 25.14"]
Ratio Decidendi
The Court found the rejection of the offer was not unreasonable because the appeal was genuinely arguable, commercially significant to the appellant, and the quantum of costs was not provided. Therefore, indemnity costs were not warranted and only party and party costs were ordered.
Court Disposition
Appellant ordered to pay respondents' costs of the appeal on a party and party basis.
Orders
- ["The appellant pay the respondents' costs of the appeal on a party and party basis."]
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment